Jpmorgan Chase & CO Sana Biotechnology, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SANA
# of Institutions
174Shares Held
121MCall Options Held
1.87MPut Options Held
1.48M-
Flagship Pioneering Inc. Cambridge, MA25MShares$65.3 Million17.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$34.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11MShares$28.8 Million0.0% of portfolio
-
Baillie Gifford & CO10.3MShares$26.8 Million0.03% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$26.6 Million0.04% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $497M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...